Soluble CD13 induces inflammatory arthritis b activating the bradykinin receptor B1

Tsou, PS; Lu, CY; Gurrea-Rubio, M; Muraoka, S; Campbell, PL; Wu, Q; Model, EN; Lind, ME; Vichaikul, S; Mattichak, MN; Brodie, WD; Hervoso, JL; Ory, S; Amarista, CI; Pervez, R; Junginger, L; Ali, M; Hodish, G; O'Mara, MM; Ruth, JH; Robida, AM; Alt, AJ; Zhang, CX; Urquhart, AG; Lawton, JN; Chung, KC; Maerz, T; Saunders, TL; Groppi, VE; Fox, DA; Amin, MA

Fox, DA (通讯作者),Univ Michigan, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA.;Fox, DA (通讯作者),Univ Michigan, Dept Internal Med, Clin Autoimmun Ctr Excellence, Ann Arbor, MI 48109 USA.

JOURNAL OF CLINICAL INVESTIGATION, 2022; 132 (11):

Abstract

CD13, an ectoenzyme on myeloid and stromal cells, also circulates as a shed, soluble protein (sCD13) with powerful chemoattractant, angiogenic, and ar......

Full Text Link